Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur Respir J. 2004 Oct;24(4):703-7.

Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension.

Author information

  • 1Dept of Internal Medicine, University Hospital, Raemistrasse 100, CH-8091, Zurich, Switzerland.

Abstract

Portopulmonary hypertension (PPHTN) is associated with poor prognosis and high perioperative mortality after orthotopic liver transplantation. This study documents the first case of a patient with PPHTN who was successfully bridged to orthotopic liver transplantation with i.v. iloprost, a stable prostacyclin analogue. The PPHTN had resolved completely 4 months after successful transplantation. In conclusion, portopulmonary hypertension is a relative contraindication to orthotopic liver transplantation, which should be attempted only if pulmonary haemodynamics improve with prostanoids. In this context, iloprost may be a valuable alternative to epoprostenol.

[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk